Addiction, addiction-treatment / 26.11.2025

[caption id="attachment_71554" align="aligncenter" width="500"]addiction-recovery-finding-right-rehab Photo by MART PRODUCTION[/caption] Everyone talks about getting help, but not enough people explain what that actually looks like when you’re in the middle of a mental and emotional spiral. Recovery isn’t one straight line forward. It’s a mix of reflection, courage, trial and error, and the willingness to step into something different when old patterns stop working. For many people, the turning point isn’t a single moment but a series of small decisions that help them feel safe enough, supported enough, and hopeful enough to try again. Here, we explore six ways people discover the right environment, the right therapies, and the right support systems for long-term healing. Finding a Place That Feels Safe Spiritually People don’t always realize how much their environment shapes their recovery. The tone of a program, the worldview of the counselors, and the philosophy of the community can all influence how safe someone feels opening up about their struggles. That’s why some individuals look for care that aligns with their personal beliefs, especially when their spirituality is part of their coping framework. A Christian drug rehab program is one example of how values-aligned support can make the work feel safer. Facilities like these build treatment around clinical care, emotional healing, and Christian guidance. For people who draw strength from Jesus, reading scripture, prayer, or a sense of spiritual identity, this kind of environment isn’t just comforting. It helps reduce internal conflict so they can focus on the harder emotional layers underneath their addiction or mental health patterns.
Author Interviews, Cannabis, JAMA / 25.11.2025

Editor’ note:  Cannabis and THCA/HEMP CBD products should have an active ingredient list on the container and have a Certificate of Analysis (COA). Discuss your use of THC, Cannabis or CBD products with your health care provider.  Dosing of CBD is variable, especially since it is not FDA regulated. Cannabis/CBD may interfere with other medications and should not be used in individuals with certain health conditions, including liver issues. CBD skin care products can be absorbed through the skin and have similar effects. Do not use Cannabis products including edibles and CBD if you are pregnant, nursing or may become pregnant. Do not use cannabis products if driving or operating difficult or dangerous machinery. Children should not be exposed to cannabis or CBD products. [caption id="attachment_71501" align="alignleft" width="157"]Dr. Swartz Dr. Swartz[/caption] MedicalResearch.com Interview with: James A. Swartz, PhD Professor, Jane Addams College of Social Work University of Illinois Chicago MedicalResearch.com: What is the background for this study? Response: For the past 5 1/2 years, my project team has been charged with monitoring the public health effects of adult cannabis use legalization in Illinois. To fulfill that obligation, we have monitored state data and have tried to keep informed about ongoing research on cannabis legalization and public health. Cannabinoid hyperemesis syndrome (CHS) rose to the surface of this continual monitoring through a growing number of publications indicating the prevalence of this condition was on the rise and clinical case reports. As context, for any readers unfamiliar with the clinical syndrome, CHS is a paradoxical reaction to long-term, heavy cannabis use. Instead of relieving nausea, cannabis in some people appears to trigger cycles of severe nausea, vomiting, and abdominal pain. Patients often present repeatedly to emergency departments, undergo extensive workups, and only much later does someone connect the dots and consider CHS. Resource use is substantial. CHS visits often involve repeat ED presentations, imaging, laboratory testing, and sometimes hospital admission. Even though CHS is rarely life-threatening, it is not a trivial condition from either the patient’s or the system’s perspective.

Most of the existing literature has been case reports, small series, or single-center studies. Those reports clearly show that CHS can be debilitating and is frequently misdiagnosed, but they don’t tell us much about the bigger picture:

  • How often Cannabinoid hyperemesis syndrome is showing up in emergency departments nationally
  • How those rates have changed over time, especially as cannabis policies and patterns of use have shifted
  • What the typical patient profile looks like at a population level

Our goal was to step back and use a large national emergency department database to describe CHS at scale in the United States from 2016 through 2022.

Addiction, addiction-treatment, Environmental Risks / 14.11.2025

[caption id="attachment_71431" align="aligncenter" width="500"]Does Climate Shape Recovery Photo by Jean van der Meulen[/caption] Recovery isn’t just about what happens inside therapy sessions or support groups. It’s also about what surrounds you when you step outside those doors. The air you breathe, the light on your skin, the rhythm of your days, all of it plays a quiet but measurable role in how you heal. While it might sound poetic, science has a lot to say about the way climate and setting affect the brain during recovery, from mood regulation to motivation and sleep quality. The Energy Of The Air You Breathe It’s no coincidence that people feel lighter when they’re near the ocean or calmer in the mountains. Air quality, humidity, and temperature each influence how our bodies function, which in turn affects the mind’s ability to regulate mood. A person working through recovery in a humid coastal climate may find that their breathing feels easier and their body relaxes more readily, while those in dry, cool air often experience improved energy and focus. When you’re recovering, your nervous system is recalibrating, and the smallest sensory cues can make a big difference. Studies have shown that access to clean air, greenery, and natural light helps regulate cortisol levels, the body’s main stress hormone. When those levels stabilize, people tend to feel more grounded, alert, and capable of processing the deeper emotional work that recovery requires. This is why some of the most respected treatment programs are situated in places with abundant natural beauty, offering a real physiological advantage beyond aesthetics.
Author Interviews, Cannabis, JAMA, Opiods / 13.11.2025

[caption id="attachment_71419" align="alignleft" width="150"]MedicalResearch.com Interview with:Victoria Bethel, MSN Department of Public Administration and Policy University of Georgia, Athens Victoria Bethel[/caption] MedicalResearch.com Interview with: Victoria Bethel, MSN Department of Public Administration and Policy University of Georgia, Athens   MedicalResearch.com: What is the background for this study? Response: From the same pool of commercially insured patients, we found that cannabis dispensary openings were associated with reduced opioid prescribing among patients with non-cancer pain. For this study, we examined whether cannabis dispensary openings were also associated with reduced opioid prescribing among commercially insured patients who do have a cancer diagnosis. Similar to patients without cancer, we estimated reductions in opioid prescribing after medical and recreational cannabis dispensaries open. These findings may suggest that patients who experience cancer pain are able to manage their pain with cannabis instead of requiring opioids, although we cannot directly observe substitution.
Addiction, addiction-treatment / 06.11.2025

[caption id="attachment_71316" align="aligncenter" width="500"]online-virtual-addiction-rehab Freepix Image[/caption] Walking into a treatment center can feel like the hardest step you'll ever take. The fear of judgment and the logistics of getting help often stop people before they even start. For anyone struggling in silence, the modern solution may not be found in a waiting room. It may be found online.   This post is for those who need to reclaim their life but require a different path—one that is private, respectful, and integrated into a real-world schedule. It will show how it's possible to get expert medical consultation and treatment at Aegis Medical from the safety of your own home. 

Beyond the Video Call: What Real Online Treatment Actually Is 

The core of any real treatment program isn't just a collection of services; it's a connected system of support designed for safety and healing. Think of it as having a dedicated team in your corner. 

Medical oversight 

A doctor by your side, especially in the early stages, manages the physical challenges of withdrawal and ensures you're safe. 

Therapy sessions 

A therapist who helps you unpack the "why" behind the struggle, giving you the tools to handle what comes up in life without needing to rely on substance use. 

Medication management  

Careful management of any medications that can take the edge off cravings and help your brain chemistry find its natural balance again. 

Peer support groups  

And finally, a built-in community of people who truly get it, because they're on the same path, helping to shatter the loneliness that so often feeds addiction. 
Addiction, addiction-treatment, Author Interviews, Opiods / 13.10.2025

MedicalResearch.com Interview with: [caption id="attachment_70953" align="alignleft" width="128"]Krisha S. Patel Krisha S. Patel[/caption] Krisha S. Patel Center For Pharmacy Innovation and Outcomes Geisinger College Health Sciences Scranton, PA MedicalResearch.com: What is the background for this study? Response: Hydromorphone is a powerful opioid medication approved for treating moderate to severe acute pain, as well as chronic pain that doesn’t respond to other treatments. One brand name is Dilaudid. It is much more potent than morphine, about 5 to 10 times stronger, and crosses the blood-brain barrier more efficiently. Hydromorphone comes in several forms, including oral powders, solutions, immediate- and extended-release tablets, and injectable options like intravenous, intramuscular, and subcutaneous. Like morphine, hydromorphone primarily targets the mu-opioid receptors, with some activity at delta receptors. Its higher fat solubility gives it a faster onset of action than morphine, though not as rapid as fentanyl. Due to its potency and risk for misuse and overdose, hydromorphone is typically prescribed only when other pain management options have failed. According to the RADARS StreetRx Program, in 2023, the black-market value of a 1 mg immediate-release tablet was about $15,000 annually, with extended-release tablets reaching $62,000 for a full-years supply. While previous studies have explored regional differences in the use of opioids like morphine, oxycodone, and codeine, hydromorphone has not been examined. This study aims to fill that gap by analyzing state-level and temporal trends in hydromorphone use across the US from 2010 to 2023. It draws on data from three major sources: the Drug Enforcement Administration’s Automated Reports and Consolidated Orders System (ARCOS), Medicaid, and Medicare Part D. By comparing these datasets, this report also explores how hydromorphone distribution and prescribing patterns have evolved over time.
Cannabis / 01.10.2025

Editor’ note:  Cannabis and THCA/HEMP CBD products should have an active ingredient list on the container and have a Certificate of Analysis (COA). Discuss your use of THC, Cannabis or CBD products with your health care provider.  Dosing of CBD is variable, especially since it is not FDA regulated. Cannabis/CBD may interfere with other medications and should not be used in individuals with certain health conditions, including liver issues. CBD skin care products can be absorbed through the skin and have similar effects. Do not use Cannabis products including edibles and CBD if you are pregnant, nursing or may become pregnant. Do not use cannabis products if driving or operating difficult or dangerous machinery. Children should not be exposed to cannabis or CBD products. [caption id="attachment_70829" align="aligncenter" width="500"]shopping cannabis products Photo by Kindel Media[/caption] With so many options available online and through local delivery services, it’s important to shop smart. Not every provider follows the same safety and quality standards — which means consumers must know what to look for before placing an order. Licensed and transparent providers make this easy, while unverified sources often cut corners that can put buyers at risk. Here’s a simple checklist to keep in mind before making your next purchase.

✅ Verify Licensing and Compliance

The first step in safe shopping is making sure the business is licensed and compliant with state regulations. Licensed shops are required to meet strict testing, labeling, and storage standards, ensuring safer products for customers.
  • Confirm that the business is legally operating in your area.
  • Check for customer reviews that mention professionalism and trustworthiness.
  • Avoid sellers that don’t clearly disclose compliance details.
Licensed services like Kravings Delivery in Lynwood are trusted by local customers because they prioritize compliance and accountability with every order.
Author Interviews, Opiods / 18.09.2025

PainRelief.com Interview with: [caption id="attachment_70727" align="alignleft" width="200"]Dr. Durbhakula Dr. Durbhakula[/caption] Shravani Durbhakula, MD, MPH, MBA Associate Professor of Anesthesiology, Division of Pain Medicine Vanderbilt University School of Medicine Medical Director, Comprehensive Pain Service Vanderbilt University Medical Center PainRelief.com: What is the background for this study? Response: Our study highlights the rapid rise of nitazenes—extremely potent and dangerous synthetic opioids—silently driving the current overdose crisis. Developed in the 1950s by a pharmaceutical company and never approved for clinical use, nitazenes are up to 20 times more potent than fentanyl and are undetectable with standard drug tests available in emergency rooms. These opioids are often mixed into counterfeit pills or other street drugs, posing an unseen threat. Furthermore, nitazenes interact with opioid receptors in a unique way, increasing overdose risk, heightening respiratory depression, and accelerating tolerance development, which makes them even more dangerous for users.
Author Interviews, Cannabis, Diabetes / 16.09.2025

[caption id="attachment_70686" align="alignleft" width="150"]Ibrahim Kamel, MD, MHABoston Medical Center – Brighton Clinical Instructor Boston Medical Center Boston University Dr. Kamel[/caption] MedicalResearch.com Interview with: Ibrahim Kamel, MD, MHA Boston Medical Center – Brighton Clinical Instructor Boston Medical Center Boston University   MedicalResearch.com: What is the background for this study? Response: Cannabis use carries risk for developing Type 2 diabetes.  It is important for physicians to screen for the use of cannabis to better understand each patients risk. MedicalResearch.com: What are the main findings? Response:  Clinically physicians should screen for and council on the risk of cannabis use. People should know what is the risk in the substances they use and make the choice that they feel is right. 
Addiction, addiction-treatment, Mental Health Research / 04.09.2025

[caption id="attachment_70529" align="aligncenter" width="500"]Hidden Layers of Addiction Photo by Andrea Piacquadio[/caption] Society as a whole tends to stigmatize addiction as simply a lack of willpower or a moral failing. However, decades of medical research show that addiction is a complex health condition rooted in brain chemistry, genetics, and environment. To truly understand the challenges of recovery and why relapse is so common, we need to look at the scientific layers that shape addictive behaviors.

Addiction as a Brain Disorder

Research has revealed that addiction fundamentally alters the brain’s reward circuitry. Substances such as opioids, alcohol, and stimulants flood the brain with dopamine, creating intense feelings of pleasure and reinforcing repeated use. Over time, the brain adapts to these surges by reducing its natural dopamine production. This leaves individuals struggling to feel pleasure from everyday activities and increasingly reliant on the substance. Neuroimaging studies have shown that addiction impacts the prefrontal cortex, the area responsible for decision-making and impulse control. This helps explain why people with addiction may struggle with self-control, even when they want to quit.
Addiction, addiction-treatment / 03.09.2025

[caption id="attachment_70519" align="aligncenter" width="500"]personalized-care-sobriety source[/caption] Addiction recovery is often described as a journey, and like any journey, the path looks different for everyone. In the past, treatment models relied heavily on standardized methods designed to work for the majority. While these approaches helped many, they left others struggling because their unique needs, backgrounds, and circumstances were overlooked. Today, a profound shift is taking place. Rehabilitation programs are embracing personalized care, tailoring treatment to the individual rather than forcing the individual to adapt to a rigid system. This evolution is not only making recovery more attainable but also redefining what it means to walk the road to sobriety.
Addiction, Author Interviews / 03.09.2025

[caption id="attachment_70512" align="aligncenter" width="500"]Medication-Assisted Treatment in Rural Emergency Departments Photo by Erik Mclean[/caption]

Why Medication-Assisted Treatment Matters

Opioid use disorder continues to harm communities across the United States. In 2023, more than 80,000 people died from opioid overdoses according to CDC data. Rural towns have been hit especially hard. Emergency departments in these areas are often the only place where patients can get immediate help. Medication-Assisted Treatment (MAT) is one of the most effective tools for treating opioid addiction. It combines medicines like buprenorphine or methadone with counseling. Studies show MAT reduces opioid use, lowers overdose risk, and improves long-term recovery rates. Patients who receive MAT are twice as likely to stay in treatment compared to those who do not. Emergency rooms see many patients in crisis. They are a critical access point for starting MAT. Yet, many rural hospitals still face major barriers when trying to use it.
Addiction, addiction-treatment, AI and HealthCare, Technology / 01.09.2025

Risks of Getting Addiction Advice from Chat GPT.png AI shows up in headlines and daily life. People use it for school, work, and even health questions. Some chat with AI tools and grow to rely on them for connection. Many also turn to ChatGPT for help with mental health or addiction. Is AI a good place to seek support, and why are so many people choosing it?

Why Are People Using AI for Mental Health Support?

When something feels off, many people turn to the internet for answers. Whether it is anxiety or addiction, there is a lot of information online. AI tools like ChatGPT feel accessible and immediate. People who live with mental health conditions often feel isolated, and symptoms can make reaching out for help feel hard. People living with a substance use disorder may fear being judged. Neurodivergent people may find face-to-face conversations uncomfortable. Some worry about racial discrimination. ChatGPT does not require referrals or insurance, which lowers the barrier to trying it. Work with irregular hours or caregiving responsibilities can make scheduling therapy difficult. For some, access barriers are real, which makes it harder to get the care they need. ChatGPT can seem like an easy solution. It is not a therapist and does not deliver therapy. AI is often described as a mirror that reflects what a person brings to it. Media stories have raised concerns about people relying on chatbots during mental health crises. What is the reality, and can using AI this way be harmful?
AI and HealthCare, Author Interviews, Cannabis, Pharmacology, Technology / 28.08.2025

[caption id="attachment_70470" align="alignleft" width="150"]Duncan Dobbins, PharmD, MHIGeisinger College of Health Sciences Scranton, Pennsylvania Dr. Dobbins, PharmD[/caption] MedicalResearch.com Interview with: Duncan Dobbins, PharmD, MHI Geisinger College of Health Sciences Scranton, Pennsylvania MedicalResearch.com: What prompted this commentary, and what did you find? Response: In theory, there could be a drug interaction between immunotherapy and medical cannabis. A small (N=102) observational report from Israel appeared to find that immunotherapies worked much less well in cancer patients who also used medical cannabis.1 However, a follow up report2 took about two weeks and involved manually rechecking the math and data-analysis. Several discrepancies emerged between the methods and results. Two-tailed tests were listed in the methods yet one-tailed p values appeared in the results. Arithmetic errors, some traceable to unconventional “floor” rounding, affected key percentages. Multiple p values in Table 1 (21 out of 22) could not be reproduced with the stated tests. Finally, smoking status, a key confound, was not reported. Taken together, these issues complicate interpretation and highlight how small computational slips can cascade into larger inferential uncertainty. For this follow-up report, I was asked, “Do you think AI could have double checked this math?”
Addiction, addiction-treatment / 26.08.2025

[caption id="attachment_70437" align="aligncenter" width="500"]medication-and-recovery Source[/caption] Medication-assisted recovery combines medical treatment and counseling and support to help individuals cope with substance use disorders. Successful though it has been, defining success is a complex process because individual progress is tailored to that person. Depending upon the individual, progress may revolve around lessening of cravings, more successful relationships, employment stability, or a better mental health status. Setting specific goals and tracking both medical and individual progress better helps to understand outcome. It assists in fine-tuning treatment plans and providing a sense of attainment for the patient. This article will discuss defining key measures, tracking patient progress, addressing the effect of support systems, treatment plan reviewing, and factors that affect longer-term outcome.

Defining Key Measures

To measure medication-assisted recovery progress, medical and personal advancement are equally important. Medical advancement typically consists of fewer withdrawal episodes, less craving, and overall better physical well-being. Personal advancement is observed in consistent employment, better relationships, and better emotional equilibrium. For instance, a person will demonstrate success by attending consistent counseling sessions, having daily routine consistency, and refraining from risk-taking activity. Consistency in taking prescribed medication is another important measure, because consistency is a major factor in sustained recovery. Providers are also monitoring decreased relapse rates and better support program participation. These dual measures provide a more complete understanding of whether treatment is working well. Rather than a solitary result, it is the general trend of advancement in multiple life areas that demonstrates genuine recovery growth. This balanced perspective allows both the patient and providers to gain a better view of the value of medication-assisted recovery.
Addiction, Author Interviews / 25.08.2025

[caption id="attachment_70381" align="aligncenter" width="500"]connection-mental-health-addiction Photo by Emma Bauso[/caption] Addiction is not simply the result of poor decisions or moral failure. It stems from a complex interplay of genetics, environmental factors, emotional regulation, and mental health conditions. One of the most promising avenues for disrupting the cycle of addiction is early intervention. Prioritizing timely mental health strategies offers a meaningful opportunity to support individuals before substance use disorder takes hold, potentially transforming lives and preventing long-term consequences. In this blog, we'll explore how early intervention in mental health can stop addiction before it starts, identify the warning signs, and discuss the systems and strategies that can break the addiction cycle.

Understanding the Link Between Mental Health and Addiction

The relationship between mental health and addiction is well-established. Studies show that individuals with mental health disorders, such as depression, anxiety, or bipolar disorder, are significantly more likely to engage in substance use as a way to cope with distressing symptoms. Over time, this self-medication can lead to dependence, setting in motion a toxic cycle of mental illness and substance abuse. This pattern can begin in the early stages of emotional or psychological distress. Without access to the right support systems or tools, individuals may turn to alcohol, drugs, or other addictive substances to manage overwhelming feelings. As the brain adapts to repeated substance use, withdrawal symptoms and cravings strengthen the cycle of addiction, making recovery increasingly challenging over time.
Cannabis / 21.08.2025

Editor’ note:  Discuss your use of THC, Cannabis or CBD products with your health care provider.  Cannabis/CBD may interfere with other medications and should not be used in individuals with certain health conditions, including liver issues. CBD skin care products can be absorbed through the skin and have similar effects. Do not use Cannabis products including edibles and CBD if you are pregnant, nursing or may become pregnant. Do not use cannabis products if driving or operating difficult or dangerous machinery. Children should not be exposed to cannabis or CBD products. [caption id="attachment_70363" align="aligncenter" width="500"]bridge-between-medicine-cannabis Photo by MART PRODUCTION[/caption] The landscape of medical cannabis research is evolving rapidly, with new clinical studies emerging monthly that challenge long-held assumptions about cannabinoid therapy. As healthcare professionals navigate this complex field, the need for evidence-based information has never been more critical. Recent research developments are beginning to provide the scientific foundation that both patients and practitioners have been seeking. Current State of Clinical Research Medical cannabis research has accelerated significantly in recent years, with over 300 peer-reviewed studies published in 2024 alone. Key areas of investigation include chronic pain management, epilepsy treatment, cancer-related symptoms, and neurological disorders. The National Institutes of Health has increased funding for cannabinoid research by 40% since 2022, reflecting growing institutional recognition of therapeutic potential. Clinical trials are now examining specific cannabinoid ratios and their effects on various conditions. Research teams at major medical centers are particularly focused on understanding how different compounds interact with the endocannabinoid system and influence therapeutic outcomes.
Addiction, Mental Health Research, Tobacco Research / 19.08.2025

[caption id="attachment_70329" align="aligncenter" width="500"]How Stimulants Affect the Brain’s Reward Pathway Photo courtesy of Freepik[/caption] Stimulants are substances that increase brain activity, heightening alertness, energy, and focus. Common examples include caffeine, nicotine, and amphetamines. This article explores how these compounds activate the brain’s reward pathway and produce effects that can range from a gentle lift in mood to an intense short-lived “buzz” that reinforces repeated use.

Understanding the Reward Pathway

 The brain’s reward pathway, known as the mesolimbic dopamine system, involves key regions such as the ventral tegmental area, nucleus accumbens, and prefrontal cortex. This network reinforces pleasurable behaviors by releasing dopamine which is a neurotransmitter linked to motivation and reward.  While natural activities like eating or socializing activate this system moderately, stimulants can hijack it. These trigger a much stronger and faster dopamine release. This heightened response can make the experience more compelling that encourages repeated use and increases the potential for dependence over time.
Addiction, Cannabis, Pediatrics / 02.08.2025

[caption id="attachment_70143" align="alignleft" width="200"]Dr-Michael-S-Dunbar Dr. Dunbar[/caption] MedicalResearch.com Interview with: Michael S. Dunbar, PhD Senior Behavioral Scientist RAND MedicalResearch.com: What is the background for this study? Response: Cannabis products are way stronger, or more potent, today than they were 20 years ago. In the past few decades, average levels of THC (i.e., the main substance in cannabis that leads to feeling high) in cannabis products have risen dramatically. With cannabis becoming increasingly accessible in places like the U.S., health officials have raised questions about how higher-potency products might be associated with problematic cannabis use and related harms, including cannabis use disorder. This is especially important for at-risk groups like young adults, who tend to use cannabis at higher rates than other age groups. One perspective is that people may use high-potency products less frequently and/or in lower amounts (i.e., “titrate”), which could mitigate some potential risks. Alternatively, if people use higher-potency products more frequently or heavily, it may increase potential for harm. In this study, we looked at how use of higher-potency cannabis flower correlated with use behavior and symptoms of problematic cannabis use in a sample of young adults.
Addiction / 01.08.2025

Substance Use Trends Across the New York City Metro

The New York City metro area is one of the most densely populated and diverse regions in the country—but it’s also facing a serious addiction crisis. Communities across the five boroughs and surrounding suburbs, including Long Island, are seeing sharp increases in opioid-related deaths, polysubstance use, and mental health challenges. These realities make the need for accessible, effective care—like Long Island addiction treatment at Victory Recovery Partners—more urgent than ever. [caption id="attachment_70127" align="aligncenter" width="500"]addiction-statistics-nyc Source[/caption]

Alarming Rise in Opioid Overdoses

According to the New York City Department of Health and Mental Hygiene, 2022 marked the highest number of overdose deaths ever recorded in NYC, with over 3,000 fatalities—a 12% increase from the previous year.
  • Fentanyl was involved in over 80% of these deaths
  • The Bronx had the highest rate, but all five boroughs saw significant increases
  • Men aged 35–54 were the most affected demographic
In nearby Nassau and Suffolk Counties, opioid-related deaths remain high as well, with Suffolk County reporting over 350 fatalities and Nassau more than 200. These numbers highlight how the epidemic spans urban, suburban, and rural communities alike.
Author Interviews, Cannabis / 30.07.2025

As cannabis use becomes increasingly mainstream, many individuals are seeking healthier ways to consume it. While smoking remains the most traditional method, concerns about respiratory health and long-term effects have prompted users to explore alternatives. This article delves into the health implications of smoking, vaping, and other delivery methods, providing an evidence-based comparison to help consumers make informed decisions.

Understanding the Risks of Smoking Cannabis

Smoking cannabis involves combusting the plant material, which produces smoke containing not only cannabinoids like THC and CBD but also a variety of harmful byproducts. These include tar, carbon monoxide, and carcinogenic compounds similar to those found in tobacco smoke. Research indicates that regular cannabis smoking can lead to respiratory issues such as chronic bronchitis, coughing, and phlegm production. While cannabis smoke contains fewer carcinogens than tobacco smoke, it still poses risks to lung health. However, unlike tobacco, cannabis smoking has not been definitively linked to lung cancer, though the data remains inconclusive due to limited long-term studies. One major concern is the temperature at which cannabis is combusted, typically around 600–900°C, which generates numerous toxic compounds. Additionally, smoking delivers cannabinoids rapidly but can irritate the respiratory tract, making it less suitable for those with pre-existing lung conditions.
Cannabis / 28.07.2025

Editor's note: Discuss your use of THC, Cannabis or CBD products with your health care provider.  Dosing of CBD is variable, especially since it is not FDA regulated. Cannabis/CBD may interfere with other medications and should not be used in individuals with certain health conditions, including liver issues. CBD skin care products can be absorbed through the skin and have similar effects. Do not use Cannabis products including edibles and CBD if you are pregnant, nursing or may become pregnant. Do not use cannabis products if driving or operating difficult or dangerous machinery. Children should not be exposed to cannabis or CBD products. [caption id="attachment_70032" align="aligncenter" width="500"]Cannabinoids and Endocannabinoids Freepik image[/caption] The human body is a complex network of systems working harmoniously to maintain balance and health. One of the lesser-known but critically important systems is the endocannabinoid system (ECS). This intricate system plays a vital role in regulating a variety of physiological processes, including mood, pain sensation, appetite, and immune response. Central to the ECS are cannabinoids: both those produced naturally within the body and those introduced from external sources like cannabis. Understanding how cannabinoids interact with the endocannabinoid system is key to unlocking their therapeutic potential and appreciating their impact on human health.

What is the Endocannabinoid System?

The endocannabinoid system is a biological network found in all vertebrates, including humans. It consists primarily of three components:
  • Endocannabinoids
  • Cannabinoid receptors
  • Enzymes that synthesize and degrade endocannabinoids
Discovered in the early 1990s, the ECS has since been recognized as a crucial regulator of homeostasis—the body’s internal balance. Endocannabinoids are naturally occurring lipid-based neurotransmitters, the most well-known being anandamide and 2-arachidonoylglycerol (2-AG). These molecules bind to cannabinoid receptors, which are located throughout the body, including the brain, immune cells, organs, and connective tissues. The two primary receptors are CB1 and CB2, each with distinct functions and locations. CB1 receptors are predominantly found in the central nervous system, influencing memory, pain, and motor control, while CB2 receptors are mostly present in the peripheral nervous system and immune cells, modulating inflammation and immune responses.
Addiction, addiction-treatment, Author Interviews / 27.07.2025

MedicalResearch.com Interview with: [caption id="attachment_70015" align="alignleft" width="152"]Prof. Yonatan M. Kupchik PhD andLiran Levi, PhD student Faculty of Medicine at Hebrew University Prof. Kupchik[/caption] Prof. Yonatan M. Kupchik PhD and [caption id="attachment_70017" align="alignleft" width="138"]Liran Levi L. Levi[/caption] Liran Levi, PhD student Faculty of Medicine at Hebrew University MedicalResearch.com: What is the background for this study? Response: Motivated behavior is driven by a group of brain regions called collectively the reward system. This neural system is at the heart of every decision we make about our actions - it integrates information about the world and decides whether to perform a behavior or not based on the predicted reward/benefit. The key molecule in this process is dopamine - whenever we perform a behavior that provides a reward dopamine is released in the reward system and reinforces this behavior. Drugs of abuse exploit this system - they cause abnormally high levels of dopamine, and thus force the reward system to seek drugs constantly, even after prolonged withdrawal. From a neurobiological perspective, that is how we view substance dependence - the reward system drives people to seek for the reward.
Addiction, addiction-treatment, Opiods / 23.07.2025

[caption id="attachment_69662" align="alignleft" width="150"]Maria Gikoska, MBSGeisinger College of Health Sciences Scranton, PA 18509 Maria Gikoska[/caption] MedicalResearch.com Interview with: Maria Gikoska, MBS Geisinger College of Health Sciences Scranton, PA 18509 MedicalResearch.com: What is the background for this study? Response: Opioid use disorder (OUD) is a chronic condition that continues to substantially impact public health in the United States (U.S.), with approximately 5.7 million people affected in 2023. Buprenorphine, a partial mu-opioid receptor agonist, is widely used for treating OUD due to its safety profile, high treatment retention, and effectiveness in reducing opioid-related mortality. Since its approval in 2002, its use has increased, though not uniformly across states. Factors such as the now- eliminated X-waiver, telemedicine expansions during the COVID-19 pandemic, and differing state level policies have influenced buprenorphine access. The study sought to evaluate national and state-level pattern in buprenorphine distribution from 2019-2023 to understand disparities and inform public health interventions.
Addiction / 22.07.2025

[caption id="attachment_69633" align="aligncenter" width="500"]spirituality-recovery-cravings-addiction Photo by Anastasia Shuraeva[/caption] Addiction has a way of hollowing out the life it invades, draining families, eroding bodies, and dismantling communities one relapse at a time. We know the patterns: the cycle of detox, a brief clean stretch, the weight of shame, the familiar collapse. But medicine is evolving, and we’ve learned that the way forward requires a mix of evidence-based care, layered psychological support, and a deeper look at what keeps a person whole. Unraveling The Physiology Of Craving Cravings are not merely willpower issues. They’re complex chemical signals rooted in neuroadaptation, reward circuitry, and stress response gone haywire. Chronic use alters dopaminergic pathways, rewiring what the brain identifies as a “need” and creating persistent triggers linked to environmental cues and emotional states. Managing these signals isn’t just about abstinence. It requires targeted pharmacotherapies and cognitive interventions that interrupt the loop before a slip becomes a spiral. Medications like buprenorphine and naltrexone have changed the way we stabilize opioid and alcohol dependencies, reducing post-acute withdrawal and lowering the risk of overdose during vulnerable windows. But medications alone won’t rebuild a life stripped of social connection and purpose. Addressing these biological underpinnings is only the first layer of work.